new post
StocksRunner logo
mail
search
 
menu
 
Capricor Therapeutic
$26.95
+323.74%
 
  Create Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

CAPR Stock Analysis & IQ Rating | Capricor Therapeutics Inc.

 
 
 

CAPR

 

Capricor Therapeutics Inc

$26.95

 
+$20.59 | +323.74%
 
  Create Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$40.37
 
 
MKT CAP
$1.01B
 
52W Low
$4.3
 
 
VOL
$20.72M
 
P/E Ratio
N/A
 
 
AVG VOL
$1.98M
 
RSI
92.04
 
 
TREND
Uptrend
 
 
 

CAPR Stock IQ

 
lock  Login to see Capricor Therapeutics Inc (CAPR) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

CAPR Target Price

 
 
 

Strengths

 

CAPR Rewards

 Upgraded on attractively valued

CAPR Rewards

 Investors confidence is positive

 
 

CAPR Price Performance

 
 

$6.22   (+333.28%)

$6.48   (+315.90%)

$7.41   (+263.70%)

$13.88   (+94.16%)

 
 
1year
6month
3month
1month
 

CAPR Risk Level

 

CAPR has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

 
 

Risks Indicators

 High volatilty

 
 
CAPR Risk Level
Low
LOW
HIGH
 

CAPR Analysts Opinion

 

CAPR overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 
 
 

Rating

×
 

Rating

 

CAPR Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

CAPR Momentum Analysis

 Price value has negative momentum

 

Activity

×
 

Activity

 

CAPR Activity Sentiment

 Investors confidence is positive

 

Future

×
 

Future

 
 
 

CAPR Analysts Opinion

CAPR Analysts opinion is negative but has improved from the past 3 months

 

CAPR Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction, and growth potential

 
80%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
0%
NA
 

CAPR Street Sentiment 

CAPR Street Sentiment is bullish and have negative views on the near-term outlook

 

CAPR Performance Sentiment

 
Sentiments overview associated with CAPR events and the stock performance.
 
80%
20%
Positive
Negative
4 out of 5
events present
1 out of 5
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

Technical Price Levels

 

Average key support and resistance price levels

 
lock  Login to display
 
Support
Price
 
$5.19
 
Resistance
Price
 
$4.60
 
 
Current Price Range
 
$6.51
 
 
Show methods +
 
 
CAPR Latest Analysis +
 
 
FAQ About CAPR Stock Insights
 

What is CAPR current stock price?

What are CAPR stock strengths?

What is CAPR Risk Level?

What is CAPR market cap and volume?

What is CAPR current Stock IQ?

Should I buy CAPR stock right now?

Is CAPR a Strong Buy right now?

What does a 'Strong Buy' rating mean for CAPR?

What does a 'Strong Sell' rating mean for CAPR?

What factors influence CAPR's Stock IQ?

 
 
StocksRunner

Explore our CAPR Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored CAPR Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our CAPR Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner Overview
 
StocksRunner Trending
 
StocksRunner Screener
 
StocksRunner Insights
 
StocksRunner Top Rated
 
StocksRunner Momentum
 
StocksRunner Leaders
mail
 
 

CAPR

 

Capricor Therapeutics Inc

 
 

Current Price

 

$26.95

 
+$20.59 | +323.74%
 
 
52W High
$40.37
 
 
MKT CAP
$1.01B
 
52W Low
$4.3
 
 
VOL
$20.72M
 
P/E Ratio
N/A
 
 
AVG VOL
$1.98M
 
RSI
92.04
 
 
TREND
Uptrend
 
 
 
  Create Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 

Target Price

 
 
 
 
Not Enough Information
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

CAPR Rewards

 Upgraded on attractively valued

CAPR Rewards

 Investors confidence is positive

 
 
 
 
user
 
 
 
 

CAPR Price Performance

 
 

$6.22   (+333.28%)

$6.48   (+315.90%)

$7.41   (+263.70%)

$13.88   (+94.16%)

 
 
1year
6month
3month
1month
 

CAPR Analysts Opinion

 

CAPR Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

 
 

Earnings

×
 

Earnings

 
 
 

Rating

×
 

Rating

 

CAPR Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

CAPR Momentum Sentiment

 Price value has negative momentum

 

Activity

×
 

Activity

 

CAPR Activity Sentiment

 Investors confidence is positive

 

Future

×
 

Future

 
 
 

CAPR Analysts Opinion

CAPR Analysts opinion is negative but has improved from the past 3 months

 

CAPR Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction, and growth potential

 
80%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
0%
NA
 

CAPR Street Sentiment 

CAPR Street Sentiment is bullish and have negative views on the near-term outlook

 

CAPR Risk Level

 

CAPR has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

 
 

Risks Indicators

 

 High volatilty

 
 
CAPR Risk Level
Low
LOW
HIGH
 
CAPR Performance Sentiment
 
Sentiments overview associated with CAPR events and the stock performance.
 
80%
20%
Positive
Negative
4 out of 5
events present
1 out of 5
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

Technical Price Levels

 

Average key support and resistance price levels

 
lock  Login to display
 
Support
Price
 
$5.19
 
Resistance
Price
 
$4.60
 
 
Current Price Range
 
$6.51
 
 
Show methods +
 
 
 
 
 
 

CAPR Stock IQ

 
 
 
lock  Login to unlock Capricor Therapeutics Inc (CAPR) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

CAPR Latest Analysis

 
 
 

Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy. Capricor Therapeutics (NASDAQ: CAPR) a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases today announced positive topline results from its pivotal Phase 3 HOPE-3 trial evaluating Deramiocel the Companys investigational cell therapy for the treatment of Duchenne muscular dystrophy (DMD).

 

Today

$26.95 | +323.74%
 
Activity

Unpacking the Latest Options Trading Trends in Capricor Therapeutics. Whales with a lot of money to spend have taken a noticeably ish stance on Looking at options history for Capricor Therapeutics (NASDAQ:) we detected 13 trades.If we consider the specifics of each trade it is accurate to state that 61% of the investors opened trades with ish expectations and 23% with bearish.From the overall spotted trades 7 are puts for a total amount of $498769 and 6 calls for a total amount of $468675.Analyz

 

Mon Nov 24, 2025

$4.64 | -19.30%
 
Activity

Capricor Therapeutics (CAPR) Stock Is Sliding Today: Should Retail Investors Be Worried?. ) shares are trading lower Monday morning after the company reported new data from its exosome-based drug delivery platform. Here’.s what investors .CAPR is testing critical support. The work focuses on efficiently packaging small interfering RNAs and phosphorodiamidate morpholino oligomers into engineered exosomes derived from 293F cells using optimized electroporation conditions.Capricor said both sc

 

Mon Nov 24, 2025

$4.64 | -19.30%
 
Momentum

Roth Capital Maintains Capricor Therapeutics (CAPR) Buy Recommendation. Fintel reports that on November 12 2025 Roth Capital maintained coverage of Capricor Therapeutics (NasdaqCM:CAPR) with a Buy recommendation. Analyst Price Forecast Suggests 257.35% Upside

 

Thu Nov 13, 2025

$5.77 | -1.70%
 
Rating
 
 
 
 
 
StocksRunner

Discover CAPR Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of CAPR. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our CAPR Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

CAPR Stock trends

CAPR Stock performance

CAPR Stock analysis

CAPR investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

CAPR Runner Alarm

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing CAPR

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing CAPR

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.